Will Medicare Patients Get A Cut Of Prescription Deals?

(Credit: Burlingham via Shutterstock) Medicare enrollees, who have watched their out-of-pocket spending on prescription drugs climb in recent years, might be in for a break. Federal officials are exploring how beneficiaries could get a share of certain behind-the-scenes fees and discounts negotiated by insurers and pharmacy benefit managers, or PBMs, who together administer Medicare’s Part D drug program.

Topics:  credit   burlingham   shutterstock    medicare s part d   the centers    medicaid services cms    rep earl buddy carter r-ga    while medicare   dir   pressure   rep morgan griffith r-va    senate   chuck grassley r-iowa    july   cms administrator seema verma   department   human services   capitol hill   ellen   new york city s   queens   trump   april   it s   kaiser family   foundation    kaiser health news   supporters   the pharmaceutical care management association pcma     in medicare part d   mark merritt   pcma   enrollees    cvs health   express scripts   jennifer luddy   medicare payment advisory commission   congress   commissioner jack hoadley   tara o neill hayes   american action forum    they    there s   correction   november   medicare   federal   pbms   part d    cms   cms    it s   carter   medicare part d   october   house    a   verma   health   miller    pcma     in    medicare    september   cvs health   hayes   patients   cut   prescription   fees   program   drug   costs   coverage   out-of-pocket   prices   pharmacies   discounts   drugs   beneficiaries   change   pays   catastrophic   doughnut   hole   rule   agency   share   negotiations   year   pharmacy   month   officials   spending   rebates   letter   begins   fact   sheet   plan   negotiate   reducing   years   price   threshold   chronic   noted   higher   discussions   causing   nation   week   taxpayers   policy   buy   top   approach   long   manufacturers   gap   insurers   released   administration   company   spends   premiums   changed   advocates   seniors   climb   reach   beneficiary   
BING NEWS:
  • Warning Letters Safely Lowered Antipsychotic Prescribing in Dementia
    Overprescribing warning letters modestly cut the use of antipsychotic medications without apparent repercussion in people with dementia, a secondary analysis of a randomized trial indicated.
    04/25/2024 - 10:05 am | View Link
  • Novo Nordisk lands back in Sanders' crosshairs, this time over steep costs of Ozempic and Wegovy
    Just a few months after laying into CEOs from Bristol Myers Squibb, Merck & Co., and Johnson & Johnson about the high costs of their drugs, Sen. | Just a few months after laying into CEOs from Bristol ...
    04/25/2024 - 7:58 am | View Link
  • Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
    Patients struggle to afford popular weight-loss drugs such as Wegovy as employers limit Insurance coverage due to cost, use.
    04/25/2024 - 1:57 am | View Link
  • Medicare beneficiaries could be eligible for Wegovy coverage, study shows
    About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk's weight-loss drug Wegovy, a study published ...
    04/24/2024 - 2:29 am | View Link
  • UCLA Benefits Handsomely From Xtandi Cancer Drug Royalties Amid Controversy Over Drug Pricing
    UCLA, reaping billions from the cancer drug Xtandi developed with public funds, opposes U.S. plans to cut drug prices, spotlighting the conflict between academic profit and medication affordability ...
    04/18/2024 - 2:09 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Politics News